Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global CRISPR-Cas9 Nuclease market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Genome Editing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CRISPR-Cas9 Nuclease include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc and Sigma Aldrich, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR-Cas9 Nuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR-Cas9 Nuclease. This report contains market size and forecasts of CRISPR-Cas9 Nuclease in global, including the following market information:
Global CRISPR-Cas9 Nuclease Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR-Cas9 Nuclease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR-Cas9 Nuclease Market, by End Use, 2018-2023, 2024-2029 ($ millions)
Global CRISPR-Cas9 Nuclease Market Segment Percentages, by End Use, 2022 (%)
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Global CRISPR-Cas9 Nuclease Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CRISPR-Cas9 Nuclease Market Segment Percentages, by Application, 2022 (%)
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Global CRISPR-Cas9 Nuclease Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CRISPR-Cas9 Nuclease Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR-Cas9 Nuclease revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR-Cas9 Nuclease revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
TriLink BioTechnologies
Qiagen
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Horizon Discovery Plc
Sigma Aldrich
Genscript
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Aldevron
Takara Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR-Cas9 Nuclease, market overview.
Chapter 2: Global CRISPR-Cas9 Nuclease market size in revenue.
Chapter 3: Detailed analysis of CRISPR-Cas9 Nuclease company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by end use, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR-Cas9 Nuclease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 CRISPR-Cas9 Nuclease Market Definition
1.2 Market Segments
1.2.1 Market by End Use
1.2.2 Market by Application
1.3 Global CRISPR-Cas9 Nuclease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CRISPR-Cas9 Nuclease Overall Market Size
2.1 Global CRISPR-Cas9 Nuclease Market Size: 2022 VS 2029
2.2 Global CRISPR-Cas9 Nuclease Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CRISPR-Cas9 Nuclease Players in Global Market
3.2 Top Global CRISPR-Cas9 Nuclease Companies Ranked by Revenue
3.3 Global CRISPR-Cas9 Nuclease Revenue by Companies
3.4 Top 3 and Top 5 CRISPR-Cas9 Nuclease Companies in Global Market, by Revenue in 2022
3.5 Global Companies CRISPR-Cas9 Nuclease Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRISPR-Cas9 Nuclease Players in Global Market
3.6.1 List of Global Tier 1 CRISPR-Cas9 Nuclease Companies
3.6.2 List of Global Tier 2 and Tier 3 CRISPR-Cas9 Nuclease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By End Use - Global CRISPR-Cas9 Nuclease Market Size Markets, 2022 & 2029
4.1.2 Genome Editing
4.1.3 Genetic Engineering
4.1.4 gRNA Database/Gene Librar
4.1.5 CRISPR Plasmid
4.1.6 Human Stem Cells
4.1.7 Genetically Modified Organisms/Crops
4.1.8 Cell Line Engineering
4.2 By End Use - Global CRISPR-Cas9 Nuclease Revenue & Forecasts
4.2.1 By End Use - Global CRISPR-Cas9 Nuclease Revenue, 2018-2023
4.2.2 By End Use - Global CRISPR-Cas9 Nuclease Revenue, 2024-2029
4.2.3 By End Use - Global CRISPR-Cas9 Nuclease Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CRISPR-Cas9 Nuclease Market Size, 2022 & 2029
5.1.2 Biotechnology Companies
5.1.3 Pharmaceutical Companies
5.1.4 Academic Institutes
5.1.5 Research and Development Institutes
5.2 By Application - Global CRISPR-Cas9 Nuclease Revenue & Forecasts
5.2.1 By Application - Global CRISPR-Cas9 Nuclease Revenue, 2018-2023
5.2.2 By Application - Global CRISPR-Cas9 Nuclease Revenue, 2024-2029
5.2.3 By Application - Global CRISPR-Cas9 Nuclease Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global CRISPR-Cas9 Nuclease Market Size, 2022 & 2029
6.2 By Region - Global CRISPR-Cas9 Nuclease Revenue & Forecasts
6.2.1 By Region - Global CRISPR-Cas9 Nuclease Revenue, 2018-2023
6.2.2 By Region - Global CRISPR-Cas9 Nuclease Revenue, 2024-2029
6.2.3 By Region - Global CRISPR-Cas9 Nuclease Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America CRISPR-Cas9 Nuclease Revenue, 2018-2029
6.3.2 US CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.3.3 Canada CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.3.4 Mexico CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe CRISPR-Cas9 Nuclease Revenue, 2018-2029
6.4.2 Germany CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4.3 France CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4.4 U.K. CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4.5 Italy CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4.6 Russia CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4.7 Nordic Countries CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.4.8 Benelux CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia CRISPR-Cas9 Nuclease Revenue, 2018-2029
6.5.2 China CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.5.3 Japan CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.5.4 South Korea CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.5.5 Southeast Asia CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.5.6 India CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America CRISPR-Cas9 Nuclease Revenue, 2018-2029
6.6.2 Brazil CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.6.3 Argentina CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CRISPR-Cas9 Nuclease Revenue, 2018-2029
6.7.2 Turkey CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.7.3 Israel CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.7.4 Saudi Arabia CRISPR-Cas9 Nuclease Market Size, 2018-2029
6.7.5 UAE CRISPR-Cas9 Nuclease Market Size, 2018-2029
7 CRISPR-Cas9 Nuclease Companies Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Summary
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher CRISPR-Cas9 Nuclease Major Product Offerings
7.1.4 Thermo Fisher CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Key News & Latest Developments
7.2 TriLink BioTechnologies
7.2.1 TriLink BioTechnologies Company Summary
7.2.2 TriLink BioTechnologies Business Overview
7.2.3 TriLink BioTechnologies CRISPR-Cas9 Nuclease Major Product Offerings
7.2.4 TriLink BioTechnologies CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.2.5 TriLink BioTechnologies Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen CRISPR-Cas9 Nuclease Major Product Offerings
7.3.4 Qiagen CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.3.5 Qiagen Key News & Latest Developments
7.4 Editas Medicine
7.4.1 Editas Medicine Company Summary
7.4.2 Editas Medicine Business Overview
7.4.3 Editas Medicine CRISPR-Cas9 Nuclease Major Product Offerings
7.4.4 Editas Medicine CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.4.5 Editas Medicine Key News & Latest Developments
7.5 Caribou Biosciences
7.5.1 Caribou Biosciences Company Summary
7.5.2 Caribou Biosciences Business Overview
7.5.3 Caribou Biosciences CRISPR-Cas9 Nuclease Major Product Offerings
7.5.4 Caribou Biosciences CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.5.5 Caribou Biosciences Key News & Latest Developments
7.6 CRISPR therapeutics
7.6.1 CRISPR therapeutics Company Summary
7.6.2 CRISPR therapeutics Business Overview
7.6.3 CRISPR therapeutics CRISPR-Cas9 Nuclease Major Product Offerings
7.6.4 CRISPR therapeutics CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.6.5 CRISPR therapeutics Key News & Latest Developments
7.7 Intellia therapeutics, Inc.
7.7.1 Intellia therapeutics, Inc. Company Summary
7.7.2 Intellia therapeutics, Inc. Business Overview
7.7.3 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Major Product Offerings
7.7.4 Intellia therapeutics, Inc. CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.7.5 Intellia therapeutics, Inc. Key News & Latest Developments
7.8 Horizon Discovery Plc
7.8.1 Horizon Discovery Plc Company Summary
7.8.2 Horizon Discovery Plc Business Overview
7.8.3 Horizon Discovery Plc CRISPR-Cas9 Nuclease Major Product Offerings
7.8.4 Horizon Discovery Plc CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.8.5 Horizon Discovery Plc Key News & Latest Developments
7.9 Sigma Aldrich
7.9.1 Sigma Aldrich Company Summary
7.9.2 Sigma Aldrich Business Overview
7.9.3 Sigma Aldrich CRISPR-Cas9 Nuclease Major Product Offerings
7.9.4 Sigma Aldrich CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.9.5 Sigma Aldrich Key News & Latest Developments
7.10 Genscript
7.10.1 Genscript Company Summary
7.10.2 Genscript Business Overview
7.10.3 Genscript CRISPR-Cas9 Nuclease Major Product Offerings
7.10.4 Genscript CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.10.5 Genscript Key News & Latest Developments
7.11 Integrated DNA Technologies
7.11.1 Integrated DNA Technologies Company Summary
7.11.2 Integrated DNA Technologies Business Overview
7.11.3 Integrated DNA Technologies CRISPR-Cas9 Nuclease Major Product Offerings
7.11.4 Integrated DNA Technologies CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.11.5 Integrated DNA Technologies Key News & Latest Developments
7.12 New England Biolabs
7.12.1 New England Biolabs Company Summary
7.12.2 New England Biolabs Business Overview
7.12.3 New England Biolabs CRISPR-Cas9 Nuclease Major Product Offerings
7.12.4 New England Biolabs CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.12.5 New England Biolabs Key News & Latest Developments
7.13 Origene Technologies
7.13.1 Origene Technologies Company Summary
7.13.2 Origene Technologies Business Overview
7.13.3 Origene Technologies CRISPR-Cas9 Nuclease Major Product Offerings
7.13.4 Origene Technologies CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.13.5 Origene Technologies Key News & Latest Developments
7.14 Aldevron
7.14.1 Aldevron Company Summary
7.14.2 Aldevron Business Overview
7.14.3 Aldevron CRISPR-Cas9 Nuclease Major Product Offerings
7.14.4 Aldevron CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.14.5 Aldevron Key News & Latest Developments
7.15 Takara Bio
7.15.1 Takara Bio Company Summary
7.15.2 Takara Bio Business Overview
7.15.3 Takara Bio CRISPR-Cas9 Nuclease Major Product Offerings
7.15.4 Takara Bio CRISPR-Cas9 Nuclease Revenue in Global Market (2018-2023)
7.15.5 Takara Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
